IP Library Granted Patent US 7,335,483
Granted Patent B2
US 7,335,483 · App. 10/898,384 · Granted Feb 26, 2008

Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same

Assignee: Daiichi Pure Chemicals Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,335,483
App. No.
10/898,384
Granted
Feb 26, 2008
Kind
B2
Abstract

A method of a pretreatment of a sample for quantitating cholesterol characterized by, before measuring cholesterol contained in specific lipoproteins, treating the sample containing lipoproteins with an enzyme, the substrate of which is free cholesterol, optionally together with a reaction accelerator; a method for quantitating cholesterol in specific lipoproteins by using the above method; and a kit for quantitating cholesterol in specific lipoproteins to be used in the above quantification method. By using this quantification method, cholesterol in a specific fraction can be conveniently, accurately and efficiently quantitated fundamentally without resort to polyanion, etc. Thus, this method is appropriately usable in various automatic analyzers.

Claims (34)

1. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol oxidase, (b) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (c) a hydrogen peroxide consuming substance; and

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only, cholesterol esterase, and a color developer.

2. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (c) a coenzyme; and

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only, and cholesterol esterase.

3. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol oxidase, (b) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, (c) cholesterol esterase, and (d) a hydrogen peroxide consuming substance; and

(2) a second reagent comprising a substance, which acts upon said specific lipoprotein only, and a color developer.

4. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a coenzyme, (c) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (d) cholesterol esterase; and

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only.

5. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a coenzyme, (c) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (d) cholesterol esterase; and

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only, cholesterol oxidase, peroxidase, and a color developer.

6. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol oxidase, (b) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (c) a hydrogen peroxide consuming substance;

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only; and

(3) a third reagent comprising cholesterol esterase and a color developer.

7. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a reaction accelerator selected from

flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (c) a coenzyme;

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only; and

(3) a third reagent comprising cholesterol esterase.

8. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (c) a coenzyme;

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only; and

(3) a third reagent comprising cholesterol oxidase, cholesterol esterase, peroxidase, and a color developer.

9. A quantitation kit for cholesterol in a specific lipoprotein; comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a coenzyme, (c) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (d) coenzyme reaction product consuming substance; and

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only, and cholesterol esterase.

10. A quantitation kit for cholesterol in a specific lipoprotein, comprising the following reagents:

(1) a first reagent comprising (a) cholesterol dehydrogenase, (b) a coenzyme, (c) a reaction accelerator selected from flufenamic acid, mefenamic acid, 2,2′,6′,2″-terpyridine, tiglic acid, fusidic acid, betamethasone acetate, monensin or mevinolin, and (d) coenzyme reaction product consuming substance; and

(2) a second reagent comprising a substance which acts upon said specific lipoprotein only, cholesterol esterase, and a color developer.

Assignments (1)
CHANGE OF NAME Recorded Oct 13, 2011
From: DAIICHI PURE CHEMICALS CO., LTD.
To: SEKISUI MEDICAL CO., LTD.
Reel/Frame 027059/0837 →
Priority Claims (2)
JP 11-174624 · Jun 21, 1999 · national
JP 2000-26737 · Feb 3, 2000 · national
Continuity (2)
Division 0992681800
Related Publication 20040265939A1 · Dec 30, 2004